Source: Annual Congress 2009 - Old and new: technique and pathology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zamani, S. Demirbas (Konya, Turkey). FDG-PET/CT for monitoring the response to treatment in thoracic and pancreatic sarcoidosis. Eur Respir J 2009; 34: Suppl. 53, 3556

Member's Comments

No comment yet.

Related content which might interest you: Analysis of the solitary pulmonary nodule after surgical resection in patients using 18F-FDG integrated PET-CT scan at preoperative work-up. Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Source: Eur Respir J 2011; 37: 162-168 Year: 2011 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Imaging in the evaluation of tumour response of thoracic malignancies Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies Year: 2013 FDG-PET in diagnostic work-up of pulmonary artery sarcomas Source: Eur Respir J 2010; 35: 444-446 Year: 2010 FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Use of endosonography for diagnosis and staging of lung cancer and assessment of sarcoidosis Source: International Congress 2019 – PG9 Interventional pulmonology Year: 2019 Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 664s Year: 2007 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 A value of ultrasonographic predictors of malignancy in left adrenal gland in lung cancer patients – a comparison of EUS-b, CT and PET-CT Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Skills Course 2016 Year: 2016 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 NSCLC/SCLC diagnosis and staging of thoracic tumours Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers Source: Eur Respir J, 56 (5) 2000177; 10.1183/13993003.00177-2020 Year: 2020 Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer Source: Eur Respir J 2015; 46: 40-60 Year: 2015